As of 2025-12-23, the Intrinsic Value of Evelo Biosciences Inc (EVLO) is -54.22 USD. This EVLO valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Evelo Biosciences Inc is -10,844,100.00%.
Based on its market price of 0.00 USD and our intrinsic valuation, Evelo Biosciences Inc (EVLO) is overvalued by 10,844,100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -54.22 - -54.22 | -54.22 | -10,844,100.00% |
| P/E | (83.50) - (159.84) | (117.12) | -23423198.8% |
| DDM - Stable | (0.02) - (0.03) | (0.03) | -5282.0% |
| DDM - Multi | (0.03) - (0.04) | (0.03) | -6496.6% |
| Market Cap (mil) | 0.00 |
| Beta | -0.82 |
| Outstanding shares (mil) | 7.59 |
| Enterprise Value (mil) | 16.60 |
| Market risk premium | 4.60% |
| Cost of Equity | 36,485.17% |
| Cost of Debt | 5.00% |
| WACC | 8.16% |